Home » Topics » Science » New compound

New compound
RSS

CHM-273S peptide shows promise as antidiabetic drug in rats

June 17, 2022

Novel GLP-1 receptor agonist with improved oral bioavailability

June 16, 2022

T3SS inhibitor MBX-5452 well tolerated and reduces bacterial load in pneumonia mouse model

June 15, 2022

DA-1726 shows efficacy in diet-induced NASH mouse model

June 14, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

CHIN-117 reduces inflammation in murine model of colitis

May 27, 2022

MT-101: a potent and small molecule alpha4beta7 integrin inhibitor

May 25, 2022

Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease

May 13, 2022

Discovery of potent and orally bioavailable CSNK1A1 inhibitors

May 10, 2022

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...